As global markets navigate a mixed performance, with the S&P 500 and Nasdaq Composite marking significant gains over the past year despite recent volatility, small-cap stocks continue to capture investor interest amid fluctuating economic indicators such as the Chicago PMI and GDP forecasts. In this dynamic environment, identifying stocks with strong fundamentals becomes crucial for investors seeking stability and potential growth; characteristics include robust financial health, competitive positioning in their respective industries, and resilience in challenging market conditions.
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
SHL Consolidated Bhd
NA
16.14%
19.01%
★★★★★★
Central Forest Group
NA
6.85%
15.11%
★★★★★★
Morris State Bancshares
10.20%
-0.28%
6.97%
★★★★★★
Ovostar Union
0.01%
10.19%
49.85%
★★★★★★
Industrias del Cobre Sociedad Anónima
NA
19.08%
22.33%
★★★★★★
Tianyun International Holdings
10.09%
-5.59%
-9.92%
★★★★★★
Inverfal PerúA
31.20%
10.56%
17.83%
★★★★★☆
Compañía Electro Metalúrgica
71.27%
12.50%
19.90%
★★★★☆☆
Arab Banking Corporation (B.S.C.)
213.15%
18.58%
29.63%
★★★★☆☆
A2B Australia
15.83%
-7.78%
25.44%
★★★★☆☆
Click here to see the full list of 4659 stocks from our Undiscovered Gems With Strong Fundamentals screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: NZX Limited operates a stock exchange in New Zealand and has a market capitalization of NZ$480.72 million.
Operations: NZX Limited’s primary revenue streams include Funds Services at NZ$40.27 million, Secondary Markets at NZ$24.75 million, and Information Services at NZ$19.57 million. Capital Markets Origination contributes NZ$15.74 million to the revenue, followed by Wealth Tech with NZ$8.01 million and Regulation with NZ$3.89 million, while Corporate Services adds a smaller amount of NZ$0.10 million.
NZX has demonstrated notable financial resilience and growth, with its debt to equity ratio improving from 62.5% to 49.2% over the last five years, and a net debt to equity ratio at a satisfactory 39.2%. The company’s earnings soared by 58.9% in the past year, outpacing the industry average of 17.2%, although this includes a one-off gain of NZ$6 million impacting recent results. Earnings guidance for fiscal year 2024 was raised to NZ$45-49 million due to robust capital raising activities and increased trading volumes, suggesting positive momentum in its operations despite potential market uncertainties ahead.
NZSE:NZX Debt to Equity as at Jan 2025
Simply Wall St Value Rating: ★★★★★☆
Overview: Medprin Regenerative Medical Technologies Co., Ltd. operates in the field of regenerative medical solutions and has a market cap of CN¥2.83 billion.
Operations: Medprin generates revenue primarily through its regenerative medical solutions. The company’s net profit margin has shown a notable trend, with the latest figure recorded at 15.23%.
Medprin Regenerative Medical Technologies, a dynamic player in the medical equipment sector, reported impressive earnings growth of 118.2% over the past year, outpacing the industry’s -8.8%. The company’s net income for the nine months ended September 2024 was CNY 52.8 million, up from CNY 25.42 million in the previous year, with basic earnings per share doubling to CNY 0.8. Despite a slight increase in its debt-to-equity ratio to 0.2% over five years, Medprin maintains more cash than total debt and positive free cash flow of CNY 64.65 million as of September 2024 suggests robust financial health and potential for further growth.
SZSE:301033 Earnings and Revenue Growth as at Jan 2025
Simply Wall St Value Rating: ★★★★★★
Overview: Young Fast Optoelectronics Co., Ltd. specializes in the research, development, manufacture, and sale of touch panels for PDA devices across Taiwan, the rest of Asia, and the Americas with a market cap of NT$9.38 billion.
Operations: Young Fast Optoelectronics generates revenue primarily from its Electromechanical Business Group, contributing NT$1.39 billion, while the Optoelectronic Business Group adds NT$334.56 million.
Young Fast Optoelectronics showcases a compelling profile with its earnings growth of 67.3% over the past year, significantly outpacing the Electronic industry’s 6.6%. The company trades at 63.3% below its estimated fair value, suggesting potential undervaluation compared to peers and industry standards. Recent financials reveal net income for Q3 2024 at TWD 306.57 million, up from TWD 279.09 million a year prior, with basic EPS rising to TWD 2.02 from TWD 1.85 in the same period last year. Despite executive changes in late December, Young Fast maintains high-quality earnings and an appropriate debt level with more cash than total debt, reducing its debt-to-equity ratio from 1.3 to 0.5 over five years.
TWSE:3622 Earnings and Revenue Growth as at Jan 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NZSE:NZX SZSE:301033 and TWSE:3622.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Leave a Reply